These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27059685)

  • 21. Network meta-analysis of studies comparing closure devices for femoral access after percutaneous coronary intervention.
    Iannaccone M; Saint-Hilary G; Menardi D; Vadalà P; Bernardi A; Bianco M; Montefusco A; Omedè P; D'Amico S; Piazza F; Scacciatella P; D'Amico M; Moretti C; Biondi-Zoccai G; Gasparini M; Gaita F; D'Ascenzo F
    J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):586-596. PubMed ID: 30045086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A regional pharmacoinvasive PCI strategy incorporating selected bleeding avoidance strategies.
    Chava S; Raza S; El-Haddad MA; Priest J; Ashikaga T; Dauerman HL
    Coron Artery Dis; 2015 Jan; 26(1):30-6. PubMed ID: 25279566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of radial access versus femoral access with the use of a vascular closure device for the prevention of vascular complications and mortality after percutaneous coronary intervention.
    Téblick A; Vanderbruggen W; Vandendriessche T; Bosmans J; Haine SEF; Miljoen H; Segers V; Wouters K; Vrints C; Claeys MJ
    Acta Cardiol; 2018 Jun; 73(3):241-247. PubMed ID: 28851255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry.
    Vora AN; Peterson ED; McCoy LA; Garratt KN; Kutcher MA; Marso SP; Roe MT; Messenger JC; Rao SV
    JACC Cardiovasc Interv; 2016 Apr; 9(8):771-779. PubMed ID: 27101904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transradial Versus Transfemoral Access in Patients Undergoing Rescue Percutaneous Coronary Intervention After Fibrinolytic Therapy.
    Kadakia MB; Rao SV; McCoy L; Choudhuri PS; Sherwood MW; Lilly S; Kobayashi T; Kolansky DM; Wilensky RL; Yeh RW; Giri J
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1868-76. PubMed ID: 26718516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and rationale of the AngioSeal versus the Radial approach In acute coronary SyndromE (ARISE) trial: a randomized comparison of a vascular closure device versus the radial approach to prevent vascular access site complications in non-ST-segment elevation acute coronary syndrome patients.
    de Andrade PB; E Mattos LA; Tebet MA; Rinaldi FS; Esteves VC; Nogueira EF; França JÍ; de Andrade MV; Barbosa RA; Labrunie A; Abizaid AA; Sousa AG
    Trials; 2013 Dec; 14():435. PubMed ID: 24345099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous closure devices do not reduce the risk of major access site complications in patients undergoing elective carotid stent placement.
    McDonald JS; Kallmes DF; Lanzino G; Cloft HJ
    J Vasc Interv Radiol; 2013 Jul; 24(7):1057-62. PubMed ID: 23796093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of hospital outliers in bleeding complications after percutaneous coronary intervention.
    Hess CN; Rao SV; McCoy LA; Neely ML; Singh M; Spertus JA; Krone RJ; Weaver WD; Peterson ED
    Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):15-22. PubMed ID: 25424242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editor's Choice - Arteriotomy Closure Devices in EVAR, TEVAR, and TAVR: A Systematic Review and Meta-analysis of Randomised Clinical Trials and Cohort Studies.
    Vierhout BP; Pol RA; El Moumni M; Zeebregts CJ
    Eur J Vasc Endovasc Surg; 2017 Jul; 54(1):104-115. PubMed ID: 28438400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes of femoral closure compared to radial compression devices following percutaneous coronary intervention: the FERARI study.
    Fastner C; Behnes M; Ünsal M; El-Battrawy I; Ansari U; Mashayekhi K; Hoffmann U; Lang S; Kuschyk J; Borggrefe M; Akin I
    Heart Vessels; 2017 May; 32(5):520-530. PubMed ID: 27803954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women.
    Gewalt SM; Helde SM; Ibrahim T; Mayer K; Schmidt R; Bott-Flügel L; Hoppe K; Ott I; Hieber J; Morath T; Byrne RA; Kufner S; Cassese S; Hoppmann P; Fusaro M; Schunkert H; Laugwitz KL; Kastrati A; Schüpke S;
    Circ Cardiovasc Interv; 2018 Aug; 11(8):e006074. PubMed ID: 30354782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Same-day discharge after coronary stenting and femoral artery device closure: A randomized study in stable and low-risk acute coronary syndrome patients.
    Clavijo LC; Cortes GA; Jolly A; Tun H; Mehra A; Gaglia MA; Shavelle D; Matthews RV
    Cardiovasc Revasc Med; 2016; 17(3):155-61. PubMed ID: 27157292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel, minimally invasive access technique versus standard 18-gauge needle set for femoral access.
    Ben-Dor I; Maluenda G; Mahmoudi M; Torguson R; Xue Z; Bernardo N; Lindsay J; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1180-5. PubMed ID: 22334384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
    Saleh N; De Palma R; Settergren M; Rück A
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early ambulation after percutaneous femoral access with use of closure devices and hemostatic agents.
    Engelbert TL; Scholten A; Thompson K; Spivack A; Kansal N
    Ann Vasc Surg; 2010 May; 24(4):518-23. PubMed ID: 20451795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suitability of a 7-F ExoSeal Vascular Closure Device for Femoral Artery Punctures Made by 8-F or 9-F Introducer Sheaths.
    Goto S; Ohshima T; Ishikawa K; Yamamoto T; Nishizawa T; Shimato S; Kato K
    J Endovasc Ther; 2017 Aug; 24(4):516-520. PubMed ID: 28743227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a collagen plug arterial closure device with manual compression after endovascular interventions for peripheral artery disease.
    Fokkema TM; Minnee RC; Kock GA; Blomjous JG; Vahl AC; Leijdekkers VJ
    J Vasc Surg; 2016 Jul; 64(1):104-108.e1. PubMed ID: 27038835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial).
    Wong SC; Bachinsky W; Cambier P; Stoler R; Aji J; Rogers JH; Hermiller J; Nair R; Hutman H; Wang H;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):785-93. PubMed ID: 19695549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of using vascular closure devices for hemostasis on sheath removal after a transfemoral artery percutaneous coronary intervention.
    Su SF; Chang MY; Wu MS; Liao YC
    Jpn J Nurs Sci; 2019 Apr; 16(2):172-183. PubMed ID: 30044037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular Closure Devices For Axillary Artery Access: A Systematic Review and Meta-Analysis.
    Koziarz A; Kennedy SA; Awad El-Karim G; Tan KT; Oreopoulos GD; Kalra S; Etz CD; Rajan DK; Mafeld S
    J Endovasc Ther; 2024 Oct; 31(5):763-771. PubMed ID: 36625294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.